Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib-Reference-Cited by-全球学者库

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib

Published:2016-05-03 Issue:17 Volume:315 Page:1844
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Hammel Pascal¹,Huguet Florence²,van Laethem Jean-Luc³,Goldstein David⁴,Glimelius Bengt⁵,Artru Pascal⁶,Borbath Ivan⁷,Bouché Olivier⁸,Shannon Jenny⁹,André Thierry¹⁰,Mineur Laurent¹¹,Chibaudel Benoist¹²,Bonnetain Franck¹³,Louvet Christophe¹⁴

Affiliation:

1. Department of Digestive Oncology, Beaujon Hospital (AP-HP), Clichy, France

2. Department of Radiotherapy, Tenon Hospital (AP-HP), Paris, France

3. Department of Gastroenterology, Erasme University Hospital, Brussels, Belgium

4. Department of Medical Oncology, Prince of Wales Hospital, Sydney, Australia5Australasian Gastrointestinal Trials Group (AGITG), Camperdown, Australia6Prince of Wales Clinical School, University of New South Wales, Sydney, Australia

5. Department of Radiology, Oncology, and Radiation Science, University of Uppsala, Uppsala, Sweden

6. Department of Gastroenterology, Jean Mermoz Hospital, Lyon, France

7. Department of Gastroenterology, Saint-Luc University Clinics, Brussels, Belgium

8. Department of Gastroenterology, Robert Debré Hospital, Reims, France

9. Australasian Gastrointestinal Trials Group (AGITG), Camperdown, Australia6Prince of Wales Clinical School, University of New South Wales, Sydney, Australia11Department of Medical Oncology, Nepean Hospital NSW, Sydney, Australia

10. Department of Medical Oncology, Saint-Antoine Hospital (AP-HP), Paris, France

11. Department of Radiotherapy and Medical Oncology, Sainte-Catherine Institute, Avignon, France

12. Department of Medical Oncology, Franco-British Hospital Institute, Levallois-Perret, France15Oncology Multidisciplinary Research Group (GERCOR), Paris, France

13. Department of Methodology and Quality of Life in Oncology, Hospital Minjoz, Besançon, France

14. Department of Medical Oncology, Institute Mutualiste Montsouris, Paris, France

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 786 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-institutional review of adverse events associated with irreversible electroporation in the treatment of locally advanced pancreatic cancer;Surgery;2024-03

2. Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer after FOLFIRINOX chemotherapy;Clinical and Translational Radiation Oncology;2024-03

3. Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label phase 2 study;Radiotherapy and Oncology;2024-02

4. Stereotactic body radiotherapy plus rucosopasem in locally advanced or borderline resectable pancreatic cancer: GRECO-2 phase II study design;Future Oncology;2024-01-24

5. Up modulation of dose‐averaged linear energy transfer by simultaneous integrated boost in carbon‐ion radiotherapy for pancreatic carcinoma;Journal of Applied Clinical Medical Physics;2024-01-23